Target intelligence / Profile preview

Bromodomain and Extraterminal Domain Proteins (BET Proteins)

Target
BET Proteins
Molecular classification
Epigenetic reader, Transcription factor
01

Overview

Bromodomain and extraterminal domain (BET) proteins are a family of proteins, including BRD2, BRD3, BRD4, and BRDT, characterized by two tandem N-terminal bromodomains that recognize acetylated lysine residues on histones, an extraterminal (ET) domain involved in recruiting components of the transcriptional complex, and in some members (BRD4/BRDT), a C-terminal domain important for protein interactions. BET proteins regulate chromatin structure and gene expression, playing crucial roles in cellular processes such as cell cycle progression, proliferation, differentiation, inflammation response, and oncogenesis. Inhibitors of BET proteins block the interaction between bromodomains and acetylated histones, repressing transcriptional programs driven by key oncogenes.

Other names
BRD2BRD3BRD4BRDT
02

Mechanism of action

Reversibly binds to bromodomains, preventing interaction with acetylated histones and disrupting chromatin targeting, repressing transcriptional programs.

03

Biological functions

Cell cycle progressionProliferationDifferentiationInflammation responseGene expression regulationChromatin remodelingTranscription regulation
04

Disease associations

CancerInflammationViral infection
05

Safety considerations

EfficacySide effects
06

Interacting drugs

JQ1

2 more in the full profile.

Beyond the preview

Go deeper on Bromodomain and Extraterminal Domain Proteins (BET Proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bromodomain and Extraterminal Domain Proteins (BET Proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call